Please enable JavaScript.
Coggle requires JavaScript to display documents.
Bispecific ADCs - Coggle Diagram
Bispecific ADCs
Targets
Expression on tumor cells
Expression on healthy cells
Benchmarking and competition
Internalization
Previous clinical outcomes
Clinical indications
Clinical outcomes
Toxin resistances
Formats
Valency
Drug/Antibody Ratio (DAR)
Developability
FTO or licence cost
Engineering
Conjugation technologies
FTO or licence cost
Developability
Site-specific
Natural aa
Non-natural aa
Glycans
Stochastic + purification of desired isomer
Linker
FTO or licence cost
Developability
Payload (=toxin)
Mono or dual-payload
Efficacy
Type
TopoI Inhibitor
Tubulin Inhibitor
Toxicity